Talis Biomedical (TLIS) Held by Superinvestors
TALIS BIOMEDICAL CORP (TLIS) is currently held by 1 superinvestors tracked by InsiderSet, with a combined reported market value of approximately $1.11M based on the latest available SEC Form 13F filings for the quarter ended December 31, 2023.
Greenlight Capital is currently the largest disclosed institutional shareholder of TLIS tracked by InsiderSet, reporting ownership valued at approximately $1.11M in its December 31, 2023 SEC Form 13F filing.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed TLIS value among the investors covered in this analysis. Major shareholders include Greenlight Capital, and several other long-term asset managers with concentrated positions in TALIS BIOMEDICAL CORP (TLIS).
This page ranks the largest institutional TLIS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Greenlight Capital | David Einhorn | 0.05% | 149,052 | $1,110,437 | — | — | — |
Frequently asked questions about TLIS
Who are the largest superinvestors holding TLIS?
The largest superinvestors holding TLIS in the latest SEC Form 13F filings include Greenlight Capital. InsiderSet ranks these superinvestors by their latest reported TLIS position.
What does the TLIS superinvestors page include?
This page tracks TLIS positions reported by a curated group of notable institutional investors and fund managers through SEC Form 13F. TALIS BIOMEDICAL CORP (TLIS) on this page reflects disclosed 13F holdings among those superinvestors, not every institutional shareholder of the stock.
How many superinvestors hold TLIS?
InsiderSet currently tracks 1 superinvestors reporting TLIS holdings in the latest available 13F data. This is the curated set on this page, not the total number of institutions that own TLIS.
How much TLIS stock do superinvestors hold?
Superinvestors tracked by InsiderSet disclosed approximately $1.11M in TLIS holdings for Q4 2023. This figure is reported 13F value as of the filing period, not necessarily today's market value, and it covers the curated superinvestors on this page rather than every institutional filer.
When were TLIS superinvestor holdings last updated?
The latest TLIS superinvestor holdings on InsiderSet are based on SEC Form 13F filings for the quarter ended December 31, 2023. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time holdings.
Are superinvestor TLIS holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by these superinvestors as of the end of the reporting quarter. A superinvestor may have changed its TLIS position after the reporting date.
Are superinvestors buying or selling TLIS?
Buying and selling can be analyzed by comparing TLIS positions across consecutive 13F reporting periods. InsiderSet's TLIS Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View TLIS ownership changes.
How have superinvestor TLIS holdings changed over time?
InsiderSet tracks TLIS holdings among these superinvestors across multiple 13F reporting periods, so holder counts, reported value, and reported shares can be compared over time.